HyperVention empowers hypertensive individuals to manage their condition by analyzing blood pressure data to optimize medication timing. The platform generates personalized drug schedule recommendations based on identified blood pressure "hotspots." This targeted approach aims to reduce the risk of severe cardiovascular events like strokes and heart attacks associated with uncontrolled hypertension.
Funding
$120K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Hypertensive patients often struggle with adhering to complex medication schedules, leading to inconsistent treatment and suboptimal health outcomes. This non-adherence can result in increased blood pressure, higher risk of cardiovascular events, and greater healthcare costs.
Solution
HyperVention leverages data-driven algorithms to personalize medication schedules for hypertensive patients, optimizing treatment adherence and improving overall health outcomes. By analyzing patient-specific data, the platform creates tailored schedules that are easier to follow, thereby promoting consistent medication intake. This personalized approach aims to address the challenges of managing hypertension effectively, reducing the risk of complications and lowering healthcare expenditures associated with uncontrolled blood pressure. The platform uses patient survey data to inform its algorithms.
Target Audience
The primary target audience includes hypertensive patients seeking to improve medication adherence and manage their blood pressure more effectively.
Features
- Personalized medication schedules based on individual patient data
- Data-driven algorithms to optimize treatment adherence